Akums Drugs and Pharmaceutical (AKUMS) — Free Cash Flow Generation Index
Akums Drugs and Pharmaceutical (AKUMS) has a Free Cash Flow Generation Index of 0.41x as of March 2025. Free cash flow of Rs1.93 Billion represents 0% of operating cash flow (Rs4.65 Billion). See AKUMS current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Akums Drugs and Pharmaceutical Free Cash Flow Generation Index (2022–2025)
Historical FCF Generation Index trend for Akums Drugs and Pharmaceutical across 4 annual periods. Explore how well can Akums Drugs and Pharmaceutical service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Akums Drugs and Pharmaceutical (2022–2025)
Year-by-year Free Cash Flow Generation Index for Akums Drugs and Pharmaceutical. For the full company profile including market capitalisation, see AKUMS market cap.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.41x | Rs1.93 Billion | Rs4.65 Billion | Rs2.72 Billion | ▲ +10.6% |
| 2024 | 0.38x | Rs1.87 Billion | Rs4.98 Billion | Rs3.11 Billion | ▲ +143.5% |
| 2023 | -0.86x | Rs-1.52 Billion | Rs1.77 Billion | Rs3.29 Billion | ▲ +87.8% |
| 2022 | -7.09x | Rs-2.26 Billion | Rs318.54 Million | Rs2.58 Billion | — |